Agilent Technologies, Inc. (A)
Founded in 1999, Agilent Technologies became the largest Silicone Valley IPO of its time. They produce and sell optics, semiconductors, and EDA software, test, and measurement equipment for electronics. With over 13,000 companies using products and services from Agilent, they have become a leader in healthcare software and tech products, and have proven over the years to be a consistently profitable company with an 18.31% profit margin as of 2022.
J-Score: 26/30 - Buy
Acer Therapeutics Inc. (ACER)
Founded in 1991, and public in 2017, Acer Therapeutics is a pharmaceutical company that specializes in the development and commercialization of therapies for rare and life-threatening diseases. While they provide a solid product with a good goal in mind, Acer has only started earning a revenue in 2021, and has operated at a loss since they have gone public. They lack a good infrastructure and the means the truly commercialize their products at a high rate.
J-Score: 4/30 - Avoid
ADMA Biologics, Inc. (ADMA)
Founded in 2004, ADMA Biologics focuses on the manufacturing, marketing, and development of plasma products used for the prevention and treatment of infectious diseases. While they have shown growth in revenue, having inconsistent earnings paired with a debt that is more than four times their cash on hand, their operations seem unsustainable.
J-Score: 6/30 - Avoid